Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sambit Das

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
Advances in Therapy|December 5, 2024
Efficacy of Dapagliflozin + Sitagliptin + Metformin Versus Sitagliptin + Metformin in T2DM Inadequately Controlled on Metformin Monotherapy: A Multicentric Randomized TrialAwadhesh Kumar Singh, Ashok Kumar Das, L Sreenivasa Murthy, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 31, 2019
Consensus Recommendations on GLP-1 RA Use in the Management of Type 2 Diabetes Mellitus: South Asian Task ForceSanjay Kalra, Ashok Kumar Das, Rakesh Kumar Sahay, et al.
Cureus|July 31, 2025
Expert Consensus Statement on Simplified Glycemic Care in Patients With Type 2 Diabetes MellitusBipin Sethi, Subhankar Chowdhury, Sunil M Jain, et al.
Indian Journal of Endocrinology and Metabolism|April 1, 2026
Endocrine Society of India's National White Paper on Endocrine Disrupting Chemicals - A Call for ActionGagan Priya, Narendra Kotwal, Sri V Madhu, et al.
The Journal of the Association of Physicians of India|August 8, 2017
Indian College of Physicians Position Statement on Anemia in Metabolic SyndromeManisha Sahay, Sanjay Kalra, Mangesh Tiwaskar, et al.
The Journal of the Association of Physicians of India|May 13, 2024
SGLT2i as a First-line Antihyperglycemic in the Management of Type 2 Diabetes in the Context of Indians: A Systematic Review and ConsensusAwadhesh Kumar Singh, Anoop Misra, Ashok Kumar Das, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 10, 2020
Utility of Precision Medicine in the Management of Diabetes: Expert Opinion from an International PanelSanjay Kalra, A K Das, Sarita Bajaj, et al.
BMC Nephrology|May 16, 2025
Risk factors associated with Indian type 2 diabetes patients with chronic kidney disease: CITE study, a cross-sectional, real-world, observational studyAjay Kumar, Anirban Mazumdar, A K Bhattacharjee, et al.
Cardiovascular Diabetology. Endocrinology Reports|April 23, 2026
Efficacy and safety of semaglutide injection in Indian patients with type 2 diabetes mellitus inadequately controlled on metformin: a phase 3, randomized, active-controlled trial (SIZE-DM study)Nitin Kapoor, Shehla Shaikh, Saptarshi Bhattacharya, et al.
Diabetes & Metabolic Syndrome|December 14, 2020
Cardiometabolic vigilance in COVID-19 and resource husbandry in resource-challenged times: Clinical practice- based expert opinionAshok Kumar Das, Sanjay Kalra, Krishnakumar B, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Advances in Therapy|December 5, 2024
Efficacy of Dapagliflozin + Sitagliptin + Metformin Versus Sitagliptin + Metformin in T2DM Inadequately Controlled on Metformin Monotherapy: A Multicentric Randomized TrialAwadhesh Kumar Singh, Ashok Kumar Das, L Sreenivasa Murthy, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 31, 2019
Consensus Recommendations on GLP-1 RA Use in the Management of Type 2 Diabetes Mellitus: South Asian Task ForceSanjay Kalra, Ashok Kumar Das, Rakesh Kumar Sahay, et al.
Cureus|July 31, 2025
Expert Consensus Statement on Simplified Glycemic Care in Patients With Type 2 Diabetes MellitusBipin Sethi, Subhankar Chowdhury, Sunil M Jain, et al.
Indian Journal of Endocrinology and Metabolism|April 1, 2026
Endocrine Society of India's National White Paper on Endocrine Disrupting Chemicals - A Call for ActionGagan Priya, Narendra Kotwal, Sri V Madhu, et al.
The Journal of the Association of Physicians of India|August 8, 2017
Indian College of Physicians Position Statement on Anemia in Metabolic SyndromeManisha Sahay, Sanjay Kalra, Mangesh Tiwaskar, et al.
The Journal of the Association of Physicians of India|May 13, 2024
SGLT2i as a First-line Antihyperglycemic in the Management of Type 2 Diabetes in the Context of Indians: A Systematic Review and ConsensusAwadhesh Kumar Singh, Anoop Misra, Ashok Kumar Das, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 10, 2020
Utility of Precision Medicine in the Management of Diabetes: Expert Opinion from an International PanelSanjay Kalra, A K Das, Sarita Bajaj, et al.
BMC Nephrology|May 16, 2025
Risk factors associated with Indian type 2 diabetes patients with chronic kidney disease: CITE study, a cross-sectional, real-world, observational studyAjay Kumar, Anirban Mazumdar, A K Bhattacharjee, et al.
Cardiovascular Diabetology. Endocrinology Reports|April 23, 2026
Efficacy and safety of semaglutide injection in Indian patients with type 2 diabetes mellitus inadequately controlled on metformin: a phase 3, randomized, active-controlled trial (SIZE-DM study)Nitin Kapoor, Shehla Shaikh, Saptarshi Bhattacharya, et al.
Diabetes & Metabolic Syndrome|December 14, 2020
Cardiometabolic vigilance in COVID-19 and resource husbandry in resource-challenged times: Clinical practice- based expert opinionAshok Kumar Das, Sanjay Kalra, Krishnakumar B, et al.
Pageof 10